

1,402,102 filings since 2004 · latest accepted Nov 4, 2026, 9:38 AM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Aug 6, 2026 accepted 7:33 AM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 2.02Earnings release | DocumentSEC ↗ |
May 7, 2026 accepted 7:31 AM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 2.02Earnings release | Document |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
May 6, 2026 accepted 4:01 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 1.01Material agreement2.03New debt obligation3.02Unregistered equity sale7.01Reg FD disclosure | DocumentSEC ↗ |
Apr 30, 2026 accepted 4:05 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 1.01Material agreement3.02Unregistered equity sale5.03Bylaws / fiscal year5.07Shareholder vote | DocumentSEC ↗ |
Mar 5, 2026 accepted 7:01 AM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 2.02Earnings release | DocumentSEC ↗ |
Feb 2, 2026 accepted 4:49 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 1.01Material agreement3.02Unregistered equity sale3.03Holder rights modified5.03Bylaws / fiscal year7.01Reg FD disclosure | DocumentSEC ↗ |
Jan 29, 2026 accepted 4:37 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 2.02Earnings release7.01Reg FD disclosure8.01Other events | DocumentSEC ↗ |
Nov 10, 2025 accepted 4:31 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 8.01Other events | DocumentSEC ↗ |
Nov 6, 2025 accepted 4:57 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 8.01Other events | DocumentSEC ↗ |
Nov 6, 2025 accepted 7:33 AM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 2.02Earnings release | DocumentSEC ↗ |
Aug 6, 2025 accepted 7:31 AM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 2.02Earnings release | DocumentSEC ↗ |
Jul 28, 2025 accepted 7:36 AM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 8.01Other events | DocumentSEC ↗ |
Jul 3, 2025 accepted 9:10 AM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 8.01Other events | DocumentSEC ↗ |
Jun 3, 2025 accepted 4:04 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 1.01Material agreement5.07Shareholder vote | DocumentSEC ↗ |
May 13, 2025 accepted 4:03 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 2.02Earnings release | DocumentSEC ↗ |
Mar 28, 2025 accepted 7:59 AM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 1.01Material agreement | DocumentSEC ↗ |
Mar 6, 2025 accepted 4:03 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 2.02Earnings release | DocumentSEC ↗ |
Jan 7, 2025 accepted 4:08 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 3.01Delisting notice | DocumentSEC ↗ |
Jan 2, 2025 accepted 4:04 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 5.02Officer / director change | DocumentSEC ↗ |
Nov 22, 2024 accepted 4:05 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 2.05Restructuring costs | DocumentSEC ↗ |
Nov 20, 2024 accepted 4:07 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 5.02Officer / director change | DocumentSEC ↗ |
Nov 12, 2024 accepted 4:06 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 2.02Earnings release | DocumentSEC ↗ |
Oct 16, 2024 accepted 4:37 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 1.01Material agreement | DocumentSEC ↗ |
Sep 16, 2024 accepted 6:51 AM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 5.02Officer / director change | DocumentSEC ↗ |
Aug 1, 2024 accepted 4:05 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 2.02Earnings release | DocumentSEC ↗ |
Jul 8, 2024 accepted 9:15 AM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 5.02Officer / director change | DocumentSEC ↗ |
Jul 1, 2024 accepted 4:05 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 1.01Material agreement | DocumentSEC ↗ |
May 10, 2024 accepted 4:15 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 3.02Unregistered equity sale5.03Bylaws / fiscal year5.07Shareholder vote | DocumentSEC ↗ |
May 2, 2024 accepted 4:07 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 2.02Earnings release | DocumentSEC ↗ |
Apr 29, 2024 accepted 9:00 AM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 5.02Officer / director change | DocumentSEC ↗ |
Mar 12, 2024 accepted 4:31 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 3.03Holder rights modified5.03Bylaws / fiscal year | DocumentSEC ↗ |
Mar 11, 2024 accepted 7:26 AM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 1.01Material agreement2.02Earnings release3.02Unregistered equity sale5.03Bylaws / fiscal year7.01Reg FD disclosure | DocumentSEC ↗ |
Dec 29, 2023 accepted 5:29 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 1.01Material agreement | DocumentSEC ↗ |
Dec 29, 2023 accepted 4:04 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 1.01Material agreement | DocumentSEC ↗ |
Nov 8, 2023 accepted 7:22 AM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 2.02Earnings release | DocumentSEC ↗ |
Oct 11, 2023 accepted 4:06 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 5.02Officer / director change | DocumentSEC ↗ |
Aug 3, 2023 accepted 4:08 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 2.02Earnings release | DocumentSEC ↗ |
Jul 31, 2023 accepted 4:02 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 5.02Officer / director change | DocumentSEC ↗ |
Jul 24, 2023 accepted 4:01 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 5.02Officer / director change | DocumentSEC ↗ |
Jun 28, 2023 accepted 4:20 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 2.03New debt obligation3.02Unregistered equity sale | DocumentSEC ↗ |
Jun 2, 2023 accepted 4:31 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 1.01Material agreement3.02Unregistered equity sale7.01Reg FD disclosure | DocumentSEC ↗ |
May 31, 2023 accepted 4:17 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 7.01Reg FD disclosure8.01Other events | DocumentSEC ↗ |
May 8, 2023 accepted 4:15 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 8-K/A 5.07Shareholder vote | DocumentSEC ↗ |
May 2, 2023 accepted 4:05 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 1.01Material agreement | DocumentSEC ↗ |
May 2, 2023 accepted 4:03 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 2.02Earnings release | DocumentSEC ↗ |
Apr 27, 2023 accepted 4:29 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 1.01Material agreement5.07Shareholder vote | DocumentSEC ↗ |
Mar 2, 2023 accepted 4:04 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 2.02Earnings release | DocumentSEC ↗ |
Jan 4, 2023 accepted 4:04 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 2.03New debt obligation3.02Unregistered equity sale | DocumentSEC ↗ |
Nov 9, 2022 accepted 4:05 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 2.02Earnings release | DocumentSEC ↗ |
Sep 2, 2022 accepted 4:01 PM ET | LXRXLEXICON PHARMACEUTICALS, INC. | 1.01Material agreement | DocumentSEC ↗ |